← Evidence map

ArticlePharmacoEconomics2010

The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK.

Agnes Benedict et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 20151724